New application of rebeprazole in pharmacy

A technology of rabeprazole and drug administration, which is applied in the field of pharmaceuticals, can solve the problem of no substitutes, etc., and achieve the effect of reducing the area of ​​ulcers, reducing the incidence of ulcers and bleeding, and reducing the area of ​​bleeding

Inactive Publication Date: 2011-11-09
NANJING CHANGAO PHARMA SCI & TECH CO LTD +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And within the time that can be met, there is no substitute for this class

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of rebeprazole in pharmacy
  • New application of rebeprazole in pharmacy
  • New application of rebeprazole in pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1 Rabeprazole sodium prevents and treats animal experiments on digestive tract damage caused by non-steroidal antipyretic analgesic anti-inflammatory drugs (NSAIDs)

[0025] Thirty female C57BL / 6 mice, aged 10 weeks, with an average body weight of 20 grams, were selected. The mice were placed in a room with an air filtration device, the food was standard stick-shaped solid food, sterile filtered water was used, and small pieces of sterile kapok were used as bedding in the cage, and each mouse was placed in a cage. The indoor lights are turned on and off for 12 hours a day. After one week of adaptation, the mice were divided into 15 groups for the following experiments. Give mice a suspension of rabeprazole sodium 25mg / kg and calcium carbonate 50mg / kg, prepared from corn oil. Each mouse was gavaged with 0.1 ml, and the control group was gavaged with 0.1 ml corn oil. After the mice were given the above treatment for 24 hours, the treatment was repeated once. F...

Embodiment 2

[0026] Embodiment 2 rabeprazole sodium anti-stress acute ulcer effect in rats

[0027] 1. Method:

[0028] 1.1 Replication of ulcer model and index of ulcer degree: select SD rats, half and half female, weighing 200-250 grams, and the animals are randomly divided into 3 experimental groups, 1 famotidine group and 1 blank control group. Fasted for 24 h before the experiment, and had free access to water. 30 minutes before water immersion stress in the experimental group, rabeprazole sodium (25mg / kg, 50mg / kg, 100mg / kg) was administrated into the stomach (ig) respectively, with a volume of 10ml / kg (the same below), and the famotidine group was ig Tidine (100mg / kg), above medicine all is made into required concentration with 5g / L carboxymethyl cellulose solution before using. The blank control group ig corresponding volume of normal saline. Water temperature (23±1°C), immersion stress for 5 hours, sacrifice the animals, and observe the ulcers. Ulcer index was calculated accord...

Embodiment 4

[0048] Example 4 Clinical Experiment of Rabeprazole Sodium Treating the Occurrence of Ulcer Hemorrhage under Stress

[0049] 1. Selection of clinical patients

[0050] All cases had hematemesis and melena or positive fecal occult blood test confirmed by the typical medical history, and melena caused by some traditional Chinese medicine was excluded, all had dizziness, cold sweat, pale complexion, decreased blood pressure, increased heart rate, and decreased hemoglobin Wait for the performance of hemorrhagic shock. All cases were confirmed by gastroscopy. The cases were randomly divided into two groups, oral rabeprazole sodium group (treatment group) and cimetidine injection (control group). The treatment group included 105 cases, including 73 males and 32 females; aged 58 to 80 years. Both groups of patients had acute massive bleeding for the first time, that is, ulcers were seen under the microscope and were bleeding, spurting blood or had fresh blood scabs. Except for pa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine, and relates to a new application of rebeprazole in drugs for treating acute gastric mucosal injury caused by non-steroidal anti-inflammatory drugs and stress ulcer with bleeding.

Description

technical field [0001] The invention belongs to the field of pharmacy, and relates to the treatment of acute gastric mucosal injury caused by non-steroidal anti-inflammatory drugs and the treatment of ulcer bleeding under stress, especially the use of rabeprazole in the production and treatment of non-steroidal anti-inflammatory drugs. Drug-induced acute gastric mucosal injury and the application of drugs in the occurrence of ulcer bleeding under stress. Background technique [0002] Rabeprazole or 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridine]methyl]sulfinyl]-1H-benzimidazole sodium. This compound belongs to the family of drugs known as proton pump inhibitors for the treatment of gastric and duodenal ulcers. Its structure is similar to that of other proton pump inhibitors such as omeprazole and lansoprazole and belongs to the family of pyridyl-methyl-sulfinyl-benzimidazole. The clinical application of rabeprazole is mainly in the form of its sodium salt. [0003] Pyridyl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4439A61P1/04
Inventor 商明红刘彩连李站晁阳李玮
Owner NANJING CHANGAO PHARMA SCI & TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap